- Minutes of Annual General Meeting 2024
- Disclosure of voting rights for Chair of the Board
- PCI Biotech Holding ASA - Notice of Annual General Meeting 2024
- PCI Biotech Holding ASA - Annual Report 2023
- PCI Biotech second half 2023 interim results
- PCI Biotech: Invitation to second half interim 2023 results presentation
- PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing
- PCI Biotech: European patent for mRNA delivery with fimaNAc
- PCI Biotech: Employee share option scheme
- PCI Biotech: Write-down of share capital registered
More ▼
Key statistics
As of last trade PCI Biotech Holding ASA (PCIB:OSL) traded at 2.82, -17.06% below its 52-week high of 3.40, set on Nov 06, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.64 |
---|---|
High | 3.06 |
Low | 1.64 |
Bid | 2.79 |
Offer | 2.82 |
Previous close | 1.64 |
Average volume | 973.99k |
---|---|
Shares outstanding | 37.33m |
Free float | 28.39m |
P/E (TTM) | -- |
Market cap | 105.26m NOK |
EPS (TTM) | -0.5443 NOK |
Data delayed at least 15 minutes, as of May 28 2024.
More ▼